Volcano Announces FDA 510(k) Clearance of Revolution Rotational Catheter and FFR for the s5i Integrated IV...(e('Company Sanpshot')); VOLC ) offers a...)

Date:2/7/2008

e('Company Sanpshot'));" >VOLC) offers a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart diseases and guide optimal therapies. The company's intravascular ultrasound (IVUS) product line includes ultrasound consoles that can be integrated directly into virtually any modern cath lab. Volcano IVUS offers unique features, including both single-use phased array and rotational IVUS imaging catheters, and advanced functionality options such as VH(TM) tissue characterization and ChromaFlo(R). Volcano also provides functional measurement (FM) consoles and single-use pressure and flow guide wires. Currently, more than 2,900 Volcano IVUS and FM systems are installed worldwide, with approximately half of its revenues coming from outside the United States. For more information, visit the company's website at http://www.volcanocorp.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this press release regarding Volcano's business that are not historical facts may be considered "forward-looking statements," including statements regarding the company's success and timing of product development and new product introductions, including the installations of the Volcano s5-Revo and s5-FFR Options, the expected performance enhancements of its products, the integration of our products into new or existing cath labs, and market penetration, conditions and expectations. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause Volcano's results to differ materially and adversely from the statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ from the results pre
'/>"/>

SOURCE Volcano Corporation Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5
Related biology technology :

1. Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
2. Volcano Announces Closing of CardioSpectra Acquisition
3. Volcano Announces Activities at TCT 2007: Expanded Role of IVUS in PCI to be Demonstrated
4. Volcano Corporation Announces Pricing of Common Stock Offering
5. Volcano Corporation Presentation at Bear Stearns Conference to be Webcast
6. Smart Genetics Announces Plans to Launch a New Alzheimers Risk Assessment Service
7. Bioponic Phytoceuticals Announces Record Sales Increase of 40% for the Month of January
8. Biodel Inc. Announces Pricing of Public Offering
9. Dendreon Announces Webcast Presentation at BIO CEO & Investor Conference
10. VIRxSYS Announces Interim Results from VRX496 Gene Therapy Phase II Trial
11. Exelixis Announces February 12 Webcast of Presentation at the 10th Annual BIO CEO and Investor Conference